Astal Laboratories Limited (BOM:512600)

India flag India · Delayed Price · Currency is INR
80.18
+0.18 (0.23%)
At close: Feb 12, 2026
Market Cap3.38B +309.0%
Revenue (ttm)997.92M +113.0%
Net Income99.06M +123.3%
EPS7.78 +30.5%
Shares Out42.22M
PE Ratio10.30
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,644
Average Volume8,032
Open81.00
Previous Close80.00
Day's Range78.50 - 82.89
52-Week Range72.90 - 103.20
Beta-0.81
RSI44.96
Earnings DateFeb 9, 2026

About Astal Laboratories

Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India. Astal Laboratories Limited operates as a subsidiary of Aceso Research Labs LLP. [Read more]

Industry Short-Term Business Credit Institutions, Except Agricultural
Founded 1993
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 512600
Full Company Profile

Financial Performance

In fiscal year 2025, Astal Laboratories's revenue was 636.55 million, an increase of 169.15% compared to the previous year's 236.50 million. Earnings were 89.25 million, an increase of 1037.42%.

Financial Statements